MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gastrointestinal problemsm(also see autonomic dysfunction)"

  • 2019 International Congress

    Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia

    I. Krasakov, I. Litvinenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…
  • 2019 International Congress

    Gut Feelings about Parkinson’s Disease: The Influence of the Gut Microbiota in a Rodent Model

    A. Gorecki, L. Preskey, M. Bakeberg, J. Kenna, C. Gildenhuys, S. Dunlop, F. Koengten, R. Anderton (Nedlands, Australia)

    Objective: The objective of this study was to investigate the gut microbiota in a pilot cohort of Australian patients with PD, and a rodent model…
  • 2019 International Congress

    Gastrointestinal disorders in various forms of parkinsonism

    R. Matmurodov, KH. Khalimova, EL. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To examine the types of gastrointestinal disorders in parkinsonism, depending on the form of the disease. Background: One of the non-motor autonomic disorders of…
  • 2019 International Congress

    Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)

    A. Hannoun, D. Ward, J. Flahive, J. Friedman, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…
  • 2019 International Congress

    Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

    J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)

    Objective: Parkinson’s disease (PD) is associated with an assortment of difficult to recognize non-motor symptoms, including gastrointestinal (GI) dysfunction. Recently, there have been studies reporting…
  • 2019 International Congress

    The Oral Metagenome and Metatranscriptome of Early Stage Parkinson’s Disease and their Relationship with Clinical and Functional Outcome Measures of Motor and Nonmotor Function

    D. Mihaila, J. Donegan, M. Vidal, D. Larocca, R. Ericson, S. Barns, C. Neville, R. Uhlig, F. Middleton (Syracuse, NY, USA)

    Objective: To identify sensitive and specific biomarkers of changes in the oral microbiome of subjects with early stage Parkinson’s Disease and relate these to clinical,…
  • 2019 International Congress

    The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, E. Gracheva, A. Istomina, M. Kotyleva, E. Agapova, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To investigate whether clinical phenotypes can be predicted by the assessment of gut microbiome and serum inflammatory profile of PD patients. Background: Recent evidence…
  • 2019 International Congress

    The relationship between constipation and alteration of gut microbiota in patients with Parkinson’s disease

    BI. Zao An, M. Ye (Nanjing, China)

    Objective: To  study compositional and functional differences  in the gut microbiota  and its products between  individuals with PD and matched controls,and these differences  are  or…
  • 2019 International Congress

    Intestinal nerve damage and gut dysfunction in mouse models of Parkinson’s Disease

    R. Mcquade, R. Constable, E. Lei, M. Di Natale, J. Berger, J. Kauhausen, C. Parish, D. Finkelstein, J. Furness, S. Diwakarla (Melbourne, Australia)

    Objective: This work aims to investigate gut dysfunction and enteric neuropathy in several mouse models of PD to provide insight into enteric nervous system (ENS)…
  • 2019 International Congress

    Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

    TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

    Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley